ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver transplantation"

  • 2019 American Transplant Congress

    Incisional Hernia Repair Post Liver and or Kidney Transplantation

    J. Buggs1, A. Brando2, J. Sokolich1, E. Rogers1, A. Kumar3, V. Bowers1

    1Tampa General Hospital, Tampa, FL, 2University of Tampa, Tampa, FL, 3University of South Florida, Tampa, FL

    *Purpose: The literature has demonstrated worse patient survival rates with incisional hernias in abdominal transplant patients. The purpose of this study was to evaluate patient…
  • 2019 American Transplant Congress

    Rituximab Desensitization to Liver Transplantaiton Recipients with Preformed Donor Specific Antibodies to Prevent Antibody Mediated Rejecton

    Y. Ogura, M. Shizuku, N. Kurata, K. Jobara, H. Kamei

    Transplantation Surgery, Nagoya University Hospital, Nagoya City, Japan

    *Purpose: Preformed donor-specific antibodies (DSA) are considered as a risk factor after solid organ transplantation. Strong DSA is associated with high mortality and increased risk…
  • 2019 American Transplant Congress

    Multicenter Experience Evaluating Outcomes of HCV-Seropositive Donors to HCV-Seronegative Recipients Liver Transplantation

    K. Wijarnpreecha1, B. Aqel2, S. Pungpapong1, C. Taner3, K. Reddy4, M. Leise5, R. Dickson2

    1Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, 2Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ, 3Transplant, Mayo Clinic, Jacksonville, FL, 4Transplant and Hepatobiliary Surgery, Mayo Clinic, Scottsdale, AZ, 5Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN

    *Purpose: Grafts from hepatitis C virus (HCV)-seropositive donors can now be considered for liver transplant (LT) due to the advent of direct-acting antiviral agents (DAA).…
  • 2019 American Transplant Congress

    Impact of the Pediatric End-Stage Liver Disease Growth Failure Threshold on Waitlist Mortality in Children Awaiting Liver Transplant

    S. M. Swenson, J. P. Roberts, S. Rhee, E. R. Perito

    University of California, San Francisco, San Francisco, CA

    *Purpose: To examine the impact on waitlist mortality of Pediatric End-Stage Liver Disease (PELD)’s incorporation of growth failure (GF) as a threshold variable—present or absent…
  • 2018 American Transplant Congress

    Impact of Local Liver Supply on Liver Offer Acceptance

    M. Bowring,1 S. Zhou,1 A. Massie,1 S. Gentry,1,2 D. Segev.1

    1JHU, Baltimore; 2US Naval Academy, Annapolis.

    Geographic disparity in access to deceased-donor liver transplantation is well described. The available liver supply in a DSA may affect patient and provider decisions on…
  • 2018 American Transplant Congress

    Impact of Direct Acting Antiviral Agents (DAAs) for Hepatitis C Virus (HCV)-Induced Liver Diseases on Registration and Outcome on Waiting List (WL) for Liver Transplant (LT)

    C. Antoine,1 C. Jasseron,1 F. Conti,2 S. Dharancy,3 C. Duvoux,4 A. Coilly.5

    1Medical and Scientific Department, Agence de la Biomedecine, Agence de la Biomedecine, La Plaine Saint Denis, Saint Denis, France; 2Department of Hepatology, University Hospital La Pitie, Paris, France; 3Department of Hepatology, University Hospital Huriez, Lille, Nord Pas de Calais, France; 4Department of Hepatology, University Hospital Henri Mondor, Créteil, Val de Marne, France; 5Department of Hepatology, University Hospital Paul Brousse, Villejuif, Val de Marne, France.

    2d-generation DAAs have dramatically improved the management of patients with HCV, including patients with advanced diseases. In France, since 2013, DAA have been largely used,…
  • 2018 American Transplant Congress

    T Cell Exhaustion Contributes to Operational Tolerance of Liver Allografts in Pediatric Liver Transplant Recipients

    B. Ramaswami,1 M. Marrari,2 O. Yoshida,5 X. Guo,3 W. Hoffman,3 C. Bentlejewski,2 D. Metes,1 A. Demetris,1,2 A. Zeevi,2 A. Thomson,1 G. Mazariegos,4 G. Chalasani.1,3

    1Surgery, Starzl Transplantation Institute, Pittsburgh, PA; 2Pathology, University of Pittsburgh, Pittsburgh, PA; 3Medicine, University of Pittsburgh, Pittsburgh, PA; 4Children's Hospital, University of Pittsburgh, Pittsburgh, PA; 5Gastroenterology, Ehime University Graduate School of Medicine, Toon-shi, Ehime-ken, Japan.

    Operational tolerance in the absence of immunosuppression can be successfully attained in pediatric liver transplant recipients. Although DSA are observed in a proportion of operationally…
  • 2018 American Transplant Congress

    Influence of Initial Tumor Burden and Wait Times on Post-Transplant Outcomes after Down-Staging of Hepatocellular Carcinoma (HCC)

    N. Mehta, J. Dodge, F. Yao.

    UCSF, San Francisco.

    Background: A new national policy has adopted the UNOS Region 5 down-staging protocol for liver transplant (LT) in HCC meeting the following inclusion criteria -…
  • 2018 American Transplant Congress

    The Use of LiMAx for Evaluating Donor Livers on Normothermic Machine Perfusion

    J. Schurink,1 J. de Haan,2 M. Verstegen,1 H. Metselaar,3 J. Ijzermans,1 J. de Jonge.1

    1Surgery, Erasmus MC, Rotterdam, Zuid Holland, Netherlands; 2Intensive Care Medicine, Erasmus MC, Rotterdam, Zuid Holland, Netherlands; 3Gastroenterology, Erasmus MC, Rotterdam, Zuid Holland, Netherlands.

    Due to the organ shortage, inferior quality livers from donors after circulatory arrest (DCD) are offered to relieve mortality on the waiting list. The threshold…
  • 2018 American Transplant Congress

    The Utility and Futility of Extra-Corporeal Membrane Oxygenation in Liver Transplant Recipients

    B. Nguyen, K. Dhanireddy, Y. Genyk, N. Kaur.

    University of Southern California, Los Angeles, CA.

    Extra-corporeal membrane oxygenation (ECMO) is a therapeutic modality used to treat refractory hypoxemia, and help support cardiogenic shock. These conditions are seen in liver transplant…
  • « Previous Page
  • 1
  • …
  • 94
  • 95
  • 96
  • 97
  • 98
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences